Concepedia

Anker Jørgensen

AJ

Statistics

Publications

9

Citations

520

H-Index

9

Active since

1983

Affiliations

Novo Nordisk (Denmark)(Current)

University of Copenhagen

Pfizer (United States)

Anker Jørgensen is an author at Novo Nordisk (Denmark) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1983–2009

9

Publications

9

Small-molecule agonists for the glucagon-like peptide 1 receptor

Lotte Bjerre Knudsen, Dan Kiel, Min Teng et al. · Proceedings of the National Academy of Sciences · 2007 · 227 citations · Full text

, , +17

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor

Min Teng, Michael D. Johnson, Christine K. Thomas et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 65 citations · Full text

, , +13

Novel Glucagon Receptor Antagonists with Improved Selectivity over the Glucose-Dependent Insulinotropic Polypeptide Receptor

János T. Kodra, Anker Jørgensen, Birgitte Andersen et al. · Journal of Medicinal Chemistry · 2008 · 53 citations · Full text

, , +16

Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd]indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor

Anker Jørgensen, P. JACOBSEN, L. Christiansen et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 44 citations · Full text

, , +17

Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives

Anker Jørgensen, Poul Jacobsen, Paul S. Bury et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 43 citations · Full text

, , +12

1–5 of 9